Patents Examined by Louise Leary
-
Patent number: 7479367Abstract: An in vivo assay to measure anchorage-independent growth and phenotypic stability of a certain cell population comprising subcutaneous or intramuscular injection in a mammal of a cell suspension of articular chondrocytes in an iso-osmotic liquid, the same suspension comprising articular chondrocytes in an amount equivalent to at least 1×106 chondrocytes as applied to immune-deficient mice. The outcome is linked to molecular markers. The present invention further relates to DNA chips and diagnostic tools comprising the latter to predict the outcome of ACT. Antibodies raised against positive and negative markers of chondrocyte stability can also be used for quality control on the chondrocytes. Therapeutical composition comprising stable chondrocytes are very useful for tissue repair.Type: GrantFiled: October 6, 2000Date of Patent: January 20, 2009Assignee: Tigenex N.V.Inventors: Frank Luyten, Cosimo De Bari, Francesco Dell'Accio
-
Patent number: 7087401Abstract: The present invention provides a method of detecting thermonuclease-positive staphylococci that does not require inactivation of DNase-positive/TNase-negative bacteria with heat. The method includes (a) providing a culture medium selective for growing staphylococci; (b) inoculating the culture medium with a sample; (c) incubating the inoculated culture medium under conditions effective to promote the growth of staphylococci; (d) providing an indicator system that produces a differentiable, detectable signal in the presence of thermonuclease-positive staphylococci; (e) contacting the indicator system with the inoculated, incubated culture medium, thereby forming a detection assembly; (f) incubating the detection assembly under conditions effective for generating the differentiable, detectable signal; and (g) detecting the detectable signal. The present invention also provides a culture medium for the selective identification of Staphylococcus aureus.Type: GrantFiled: June 20, 2002Date of Patent: August 8, 2006Assignee: 3M Innovative Properties CompanyInventors: Gregory P. Sandberg, Patrick A. Mach
-
Patent number: 6242197Abstract: The present invention pertains to the use of urinary trypsin inhibitor for the diagnosis of the onset of AIDS and to a kit for performing such an assay. The present invention also relates to the use of urinary trypsin inhibitor for testing the efficacy of anti-HIV drugs.Type: GrantFiled: January 19, 2000Date of Patent: June 5, 2001Assignee: Technologie Integrale LimitedInventor: Marina N. Papuashvili
-
Patent number: 6242417Abstract: The present invention relates to a hemoglobin compositions stabilized against the formation of aggregates. The present invention further relates to methods of making such hemoglobin compositions.Type: GrantFiled: April 5, 1995Date of Patent: June 5, 2001Assignee: Somatogen, Inc.Inventors: Michael J. Gerber, Douglas L. Looker, Bruce A. Kerwin
-
Patent number: 6001586Abstract: A method is provided for screening microorganisms having a selectable characteristic comprising: (a) providing a growth chamber capable of forming a plurality of discrete compartments, said compartments comprising a barrier which inhibits the diffusion of metabolites or nutrients between said compartments within said growth chamber; (b) preparing a growth medium which, by its lack of or addition of one or more metabolites or nutrients, preferentially facilitates growth of microorganisms exhibiting said selectable characteristic from microorganisms which do not exhibit said selectable characteristic; (c) inoculating said growth medium with a plurality of microorganisms, a portion of which comprise said selectable characteristic; (d) placing said inoculated growth medium into said growth chamber so as to randomly disperse said microorganisms among discrete compartments in said growth chamber; and (e) incubating said growth chamber for a suitable time and under suitable conditions to obtain a detectable disparitType: GrantFiled: March 29, 1996Date of Patent: December 14, 1999Assignee: Genencor International, Inc.Inventor: Volker Schellenberger
-
Patent number: 5922530Abstract: A dye couple compound is provided for use in a test device containing a reagent system for detecting the presence or quantity of an analyte in a sample. The reagent system comprises one or more enzymes which, in the presence of the analyte, produce an oxidizing agent in quantities indicative of the quantity of analyte in the sample. The compound of choice is meta?3-methyl 2-benzothiazolinone hydrozone!N-sulfonyl benzenesulfonate monosodium.Type: GrantFiled: December 15, 1995Date of Patent: July 13, 1999Assignee: Lifescan, Inc.Inventor: Yeung S. Yu
-
Patent number: 5871950Abstract: The present invention provides methods for treating autoimmune diseases in mammals and for preventing or treating transplantation rejection in a transplant recipient. The methods of treatment involve the use of drugs capable of suppressing expression of MHC Class I molecules. In particular the use of the drug methimazole to suppress expression of MHC Class I molecules in the treatment of autoimmune diseases and the prevention or treatment of rejection in a transplant recipient is disclosed. In addition in vivo and in vitro assays are provided for the assessment and development of drugs capable of suppressing MHC Class I molecules.Type: GrantFiled: June 5, 1995Date of Patent: February 16, 1999Inventors: Dinah S. Singer, Leonard Kohn, Edna Mozes, Motoyasu Saji, Jocelyn Weissman, Giorgio Napolitano, Fred D. Ledley
-
Patent number: 5851786Abstract: The present invention relates to methods useful for identifying compounds capable of specifically regulating actin polymerization, stress fiber formation or focal adhesion assembly by regulating G.sub..alpha.12 and/or G.sub..alpha.13 activity in cells involved in inflammatory responses, immune responses, allergic responses and neuronal responses, kits to perform such assays and methods to control disease related to such responses.Type: GrantFiled: September 27, 1995Date of Patent: December 22, 1998Assignee: National Jewish Center For Immunology and Respiratory MedicineInventor: Gary L. Johnson
-
Patent number: 5846758Abstract: A method for diagnosing autoimmune disease in mammals, including humans, is described. A blood sample is collected from a subject, and mononuclear white blood cells separated therefrom. The mononuclear cells then are cultured in vitro. Patients with autoimmune disease develop characteristic white cell aggregates with autophagocytosis in the culture. Mononuclear cells from normal patients do not exhibit this cell aggregation with autophagocytosis.Type: GrantFiled: November 30, 1995Date of Patent: December 8, 1998Assignee: His Excellency Ghassan I. ShakerInventor: Rajko D. Medenica
-
Patent number: 5846702Abstract: A new group of Os(II) and Os(III) compounds useful as redox mediators in electrochemical biosensors. These compounds have 1) low oxidation potential, 2) fast reaction kinetics between the electroactive center of an enzyme and the compound, 3) slow oxidation of osmium by oxygen, and 4) excellent solubility in aqueous medium. These mediators are particularly useful as a component of a reagent used in an electrochemical biosensor, wherein the biosensor is useful for measuring analytes from a biological fluid, such as blood.Type: GrantFiled: December 20, 1996Date of Patent: December 8, 1998Assignee: Boehringer Mannheim CorporationInventors: Zhi David Deng, Gerald F. Sigler, Nigel A. Surridge, Christopher D. Wilsey, Robert J. McEnroe, Walter W. Jernigan, Rebecca W. Muddiman
-
Patent number: 5840512Abstract: The present invention relates to a method for quantitatively determining ionized calcium in a sample by using a phospholipase, which comprises carrying out an enzyme reaction with the phospholipase in a buffer comprising a nitrogen heterocycle-binding sulfonic acid having a pK ranging 6.6 to 7.6 or a salt thereof.According to the method of the invention, the amount of ionized calcium in a sample, such as serum, can be accurately determined.Type: GrantFiled: April 3, 1996Date of Patent: November 24, 1998Assignee: Kyowa Medex Co., Ltd.Inventors: Toshio Tadano, Akira Miike, Norihiko Kayahara, Jun Umemoto
-
Patent number: 5837480Abstract: This invention relates to InhA enzyme crystals and to methods of growing said crystals. This invention is further directed to the utilization of said crystals to determine the three dimensional structure of InhA enzyme utilizing heavy atom derivatives of said crystals, and to the identification and development of compounds which inhibit the biochemical activity of InhA enzyme in bacteria and plants.Type: GrantFiled: August 21, 1996Date of Patent: November 17, 1998Assignee: Albert Einstein College of Medicine of Yeshiva University, a Division of Yeshiva UniversityInventors: James Sacchettini, John Blanchard, William R. Jacobs, Jr.
-
Patent number: 5834230Abstract: Substituted aminostyrylpyridinium salts are fluorescent dyes having advantageous characteristics when employed as viscosity probes for the measurement of viscosity in a liquid, especially in a very small volume, for example, in living cells.Type: GrantFiled: July 23, 1996Date of Patent: November 10, 1998Assignee: McGill UniversityInventors: Graham D. Darling, Seymour Heisler, deceased, Brent R. Stranix, Petra Turkewitsch, Barbara Wandelt
-
Patent number: 5824493Abstract: A method of diagnosing interstitial cystitits in an individual and a kit for the method, comprising the steps of: obtaining primary cultures of urothelial cells; selecting urothelial cells of basal type and producing secondary cultures; measuring in secondary cultures (1) percentage of single cells and percentage of large colonies; (2) determining proliferative ability; (3) determining differentiation ability; (4) determining the percentage of large colonies that express phosphotyrosine and/or nitrotyrosine; (5) measuring the percentage of apoptotic cells; (6) measuring the percentage of large colonies; and (7) comparing the percentage of the colonies to baseline values of the same parameters determined in samples of similarly cultured urothelial cells taken from individuals not suspected of having interstitial cystitis.Type: GrantFiled: February 23, 1996Date of Patent: October 20, 1998Assignee: University of Alabama Research FoundationInventor: Ada Elgavish
-
Patent number: 5811252Abstract: Detection or determination of a protease in a sample by incubating the sample with a substrate of the protease and observing proteolytic cleavage of said substrate. The substrate is a modified proenzyme containing a recognition site, e.g., an activation site, cleavable by said protease. Proteolytic cleavage of the modified proenzyme is detected by observing the resulting activity using a suitable substrate of the activated proenzyme. The protease may be e.g. an aspartic protease or a metalloprotease, and the modified proenzyme e.g. pro-urokinase having a mutant activation site which is cleavable by the protease to be determined.Type: GrantFiled: July 6, 1995Date of Patent: September 22, 1998Assignee: Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNOInventor: Johan Hendrikus Verheijen
-
Patent number: 5811256Abstract: Methods for ascertaining the sensory irritation of chemicals in vitro are described. The methods include the cultivation of neuronal cells alone, with target tissue cells, and with target tissue cells and mast cells; the introduction of a chemical to be tested; and the measuring of neuronal response in the form of ion uptake or change in membrane potential. A co-culture system of neuronal and target tissue cells for performing said methods is also described.Type: GrantFiled: October 10, 1995Date of Patent: September 22, 1998Assignee: Monell Chemical Senses CenterInventor: Bruce P. Bryant
-
Patent number: 5808052Abstract: The present invention relates to water-soluble, particularly ternary, preferably ionic, cellulose mixed ethers, more particularly to anionic water-soluble cellulose mixed ethers, as additives for drilling fluid applications.Type: GrantFiled: June 10, 1996Date of Patent: September 15, 1998Assignee: Wolff Walsrode AGInventors: Klaus Szablikowski, Werner Lange, Jorn-Bernd Pannek, Rene Kiesewetter
-
Patent number: 5795730Abstract: This invention relates to methods and the use of biological indicator systems to assess and determine the effectiveness of sterilization processes comprising the steps of contacting an indicator comprising microbial spores with a sterilant; a medium selected to germinate the spores; and calculating a germination rate of the exposed spores to determine the effectiveness of the sterilization process. A method for rapidly determining the effectiveness of the gemination rate of microbial spores with spore viability is also described.Type: GrantFiled: July 12, 1996Date of Patent: August 18, 1998Assignee: Minnesota Mining and Manufacturing CompanyInventor: Kestutis J. Tautvydas
-
Patent number: 5792621Abstract: A "reagentless" chemiluminescent biosensor and method for the determination of hydrogen peroxide, ethanol and D-glucose in water. An aqueous stream is basified by passing it through a solid phase base bed. Luminol is then dissolved in the basified effluent at a controlled rate. Oxidation of the luminol is catalyzed by the target chemical to produce emitted light. The intensity of the emitted light is detected as a measure of the target chemical concentration in the aqueous stream. The emitted light can be transmitted by a fiber optic bundle to a remote location from the aqueous stream for a remote reading of the target chemical concentration.Type: GrantFiled: June 28, 1995Date of Patent: August 11, 1998Assignee: The United States of America as represented by the Administrator of the National Aeronautics and Space AdministrationInventors: Charles E. Verostko, James E. Atwater, James R. Akse, Jeffrey L. DeHart, Richard R. Wheeler
-
Patent number: 5789191Abstract: The invention provides a cosmetic or dermatological method for detecting and/or selectively quantifying individual microorganisms, and/or whole groups of microorganisms, which are present on human or animal skin, comprising the steps ofremoving a sample of the microflora of the human or animal skin,treating the sample with a deinhibiting medium, adding the treated sample to a culture medium which exhibits favorable growth conditions for a defined group of microorganisms but unfavorable growth conditions for other microorganisms, to produce a selective culture, and incubating the selective culture over a sufficiently long period of time, to allow only the group of microorganisms for which the culture medium exhibits favorable growth conditions the opportunity to multiply, in association with metabolic products, in particular CO.sub.Type: GrantFiled: February 21, 1996Date of Patent: August 4, 1998Assignee: Beiersdorf AGInventors: Bianca Mayer, Gerhard Sauermann, Bernd Traupe, Florian Wolf